Infectious Diseases Questions

Dengue, malaria, typhoid, tuberculosis, hepatitis A and E, respiratory infections including COVID and influenza, dysentery and other diarrhoeal diseases, and viral fevers of the season. Rural areas add scrub typhus, Japanese encephalitis, and leptospirosis. Vaccine-preventable diseases like measles still occur where coverage is patchy. Which ones matter for you depends on where you live and where you travel.

Any fever in a baby under 3 months. In older children and adults, warning signs: fever with confusion or unusual sleepiness, difficulty breathing, stiff neck, non-fading rash, seizures, severe headache, persistent vomiting, or a fever above 40°C. Also fever lasting more than 3-4 days, or returning fever after seeming to recover — this is a common pattern in dengue and typhoid. If in doubt, see a doctor.

Only for bacterial infections — not viruses, which cause most sore throats, colds, coughs, and stomach bugs. Overuse of antibiotics is India's biggest driver of antibiotic resistance. A good doctor will explain why they are or aren't prescribing antibiotics; if one gives them for a viral illness, it's fair to ask why. Never save leftover antibiotics or take a family member's course — this makes future infections harder to treat.

Handwashing before meals and after the toilet is the single biggest lever. Beyond that: safe drinking water (boiled or filtered), food that's cooked and served hot, keep vaccinations current, ventilate rooms, don't share towels or personal items, and stay home when sick. For mosquito-borne diseases: eliminate standing water, use repellent and nets.

Viral infections (cold, most sore throats, flu, most gastroenteritis, dengue) usually get better on their own with rest, fluids, and symptom relief — antibiotics don't help. Bacterial infections (typhoid, pneumonia, some throat infections, urinary tract infections) often need antibiotics to clear fully. Only tests and clinical judgement can tell them apart in unclear cases. That's why doctors sometimes wait or run tests rather than prescribing immediately.

Annual flu vaccine; tetanus-diphtheria booster every 10 years; hepatitis B if not immunised as a child; hepatitis A for those without prior exposure; MMR if unclear vaccination history; varicella if never had chickenpox. Adults over 50-60 should consider shingles vaccine; over 65, pneumococcal vaccines. Pregnant women need Tdap and flu vaccine. Healthcare workers, travellers, and people with chronic conditions may need additional vaccines.

Yes — especially for people over 65, children, pregnant women, and anyone with chronic conditions (diabetes, heart disease, lung disease). Flu in these groups can be serious or fatal. Even for healthy adults, the vaccine reduces severity and prevents you from spreading flu to vulnerable family members. India's flu vaccine covers strains circulating locally; ideal timing is October-November, before the winter/monsoon flu waves.

Not every minor cut — but any deep wound, burn, or wound contaminated with soil, rust, or animal saliva warrants a booster if it's been more than 5 years since your last one. Routine boosters are recommended every 10 years for all adults. Tetanus is rare but often fatal when it happens; the vaccine is safe and cheap.

For most adults, the initial vaccination gave meaningful protection. Additional boosters are recommended for older adults, people with weakened immune systems, and those with chronic conditions — based on current government guidelines, which shift as the virus evolves. Ask your doctor for the current recommendation for your risk group.

Government hospitals offer several adult vaccines free or subsidised. Private hospitals, clinics, and vaccination centres offer the full range at cost. Some vaccines (yellow fever, JE, rabies) are only at specific centres. Ayushman Bharat centres and private teleconsults can guide you to the nearest source. Keep a personal vaccination record — most Indian adults don't have one.

COVID overlaps heavily with flu and colds — fever, cough, tiredness, body aches, sore throat. Loss of taste or smell is more distinctive to COVID. Only a test can confirm which virus is causing symptoms. The main practical difference: COVID has caused more severe illness in older adults and people with chronic conditions, and can lead to longer-lasting fatigue (long COVID) even after mild infection.

Yes, especially if you'll be around older adults, pregnant women, or people with weak immunity — knowing lets you avoid spreading. Testing also matters if symptoms are severe enough that antiviral treatment might help (which needs to start early). Home rapid tests are widely available; PCR tests are more accurate. If you test positive, isolate as advised and monitor for worsening symptoms.

Long COVID is symptoms lasting more than 12 weeks after infection — commonly fatigue, brain fog, breathlessness, palpitations, and sleep problems. It can happen after even mild initial illness. Treatment is symptomatic and often multi-disciplinary (physiotherapy, pacing, mental health support, sometimes specific medications for individual symptoms). Long COVID clinics exist in major cities. Most people gradually improve over months but a subset have prolonged symptoms.

Keep their vaccinations current (annual flu, COVID boosters, pneumococcal). Wash hands before visiting, especially with a cough or cold. Skip in-person visits when you or family members are actively ill. Improve ventilation at home. Get help with chronic conditions well-controlled — diabetes and heart disease worsen respiratory infection outcomes. Have a plan for who takes them to hospital if needed.

Difficulty breathing at rest, chest pain, confusion, blue lips or fingertips, inability to keep fluids down, oxygen saturation below 94% on a home pulse oximeter, or fever that's very high or lasting more than a few days. In children, look for fast breathing, chest indrawing, or refusal to feed. Don't wait — respiratory illness can worsen fast, especially in older adults.

Hepatitis A and E spread through contaminated water and food — usually cause short illness that resolves. Hepatitis B and C spread through blood, sexual contact, and (for B) mother to child — can become chronic and cause liver cirrhosis or cancer. Hepatitis D only occurs with B. Vaccines exist for A and B, not for C. Testing for hepatitis B is worth doing at least once in adulthood; C testing is recommended for anyone with risk factors.

Through blood (needle sharing, unscreened blood transfusions, tattoos and piercings with unsterile equipment), sexual contact, and from mother to baby at birth. It doesn't spread through casual contact, sharing food, or coughing. India has significant hepatitis B prevalence — the childhood vaccine has reduced this dramatically but many adults born before universal vaccination remain unvaccinated.

Yes — modern direct-acting antiviral drugs cure over 95% of hepatitis C cases with 8-12 weeks of oral medication. This is one of the biggest treatment advances of the last decade. The challenge is finding people who have it, since it's silent for years. Anyone with risk factors (blood transfusion before 2001, injection drug use, healthcare exposure, tattoos with unsterile equipment) should get tested.

Most people don't — chronic hepatitis is silent for years. Vague symptoms like fatigue, poor appetite, or mild upper right abdominal discomfort may appear late. Diagnosis is by blood test (hepatitis B surface antigen, hepatitis C antibody). Anyone with elevated liver enzymes on a routine test, or with risk factors, should be tested. Early diagnosis lets treatment start before serious liver damage.

Yes — for hepatitis B, close family members (spouse, children, and household contacts) should be tested and vaccinated if negative. For hepatitis C, testing sexual partners and anyone who shared needles is recommended. Casual household contact doesn't spread these viruses; children shouldn't be treated differently at home. Awareness prevents transmission and enables early treatment.

In India: chlamydia and gonorrhoea (often silent, especially in women), HPV, herpes, syphilis, and HIV. Trichomoniasis and bacterial vaginosis in women. Many STIs cause no symptoms for months or years — which is why testing matters if you've had unprotected sex or a new partner. Untreated, some cause infertility, chronic pain, or cancer.

Yes, if you've had unprotected sex with a new partner, multiple partners, or a partner whose status you don't know. HIV testing is recommended at least once for all adults. Testing is confidential, and — in government sexual health clinics — often free. Home HIV test kits are also available. Regular testing is a normal part of adult health for anyone sexually active outside a mutually monogamous relationship.

Yes — most sexually active adults will be exposed to HPV at some point. Most infections clear on their own within 1-2 years. A subset persists and can cause cervical, throat, anal, and other cancers. Vaccination in adolescence prevents most cancer-causing HPV strains. Regular cervical screening (Pap smear or HPV test) catches persistent infection before it becomes cancer.

Condoms — used correctly and consistently — reduce risk substantially but don't eliminate it for infections spread by skin contact (HPV, herpes). Vaccination for HPV and hepatitis B. Regular testing if you have new or multiple partners. Honest conversation with partners about testing and status. Reducing partner numbers, or a mutually monogamous relationship where both partners have tested, is the lowest-risk approach.

Government-run Integrated Counselling and Testing Centres (ICTCs) offer free confidential HIV testing across India. Private labs and clinics offer broader STI panels. Many sexual health clinics protect confidentiality — you don't need to give your real name for HIV testing in most cases. Teleconsultations with tele-STI services have made access easier for people uncomfortable visiting in-person clinics.

TB spreads through the air when someone with active pulmonary TB coughs, sneezes, or talks. Prolonged close contact (family members, shared workplaces) carries the highest risk. Casual brief contact rarely spreads TB. Latent TB infection (bacteria present but not causing disease or spreading) is common in India — around 40% of adults have it. Only active TB is contagious.

Persistent cough of more than 2-3 weeks (often with sputum, sometimes with blood), evening fever, night sweats, unexplained weight loss, loss of appetite, and fatigue. TB can also affect other organs — bones, kidneys, brain, lymph nodes — with more localised symptoms. Any cough lasting more than 2-3 weeks in India warrants TB testing, especially with weight loss or fever.

Yes — with a full 6-month (or longer for complicated cases) course of anti-TB drugs, most TB is fully cured. The problem is completing the course. Stopping early because you feel better leads to drug-resistant TB, which is much harder and more expensive to treat. India's national TB programme provides free treatment; DOTS (Directly Observed Treatment) is designed to support completion.

India has the world's largest TB burden — around a quarter of global cases. Reasons include high latent infection rates, poverty and malnutrition, overcrowded living, delayed diagnosis, incomplete treatment (leading to resistance), and rising diabetes (which increases TB risk). The government's End TB Strategy targets 2025 elimination but progress is uneven.

Yes — close contacts of someone with active TB should be evaluated for both active disease and latent infection. Children and immunocompromised family members are especially important to test. Preventive treatment (a course of anti-TB medication) can be given to contacts with latent infection to prevent it becoming active. Your doctor or the local TB centre will guide this.

Dengue often causes high fever, severe body and joint pain ('breakbone fever'), headache behind the eyes, and — sometimes — rash. Warning signs of severe dengue: worsening abdominal pain, persistent vomiting, bleeding from gums or nose, extreme tiredness, restlessness. Any of these needs urgent medical care. Only a blood test confirms dengue definitively; NS1 antigen in the first few days, IgM antibody later.

Stay well-hydrated (oral or intravenous fluids if needed), rest, take paracetamol for fever (never aspirin or ibuprofen — they raise bleeding risk in dengue), monitor platelet count as your doctor advises, and watch for warning signs of severe dengue. Most people recover in 1-2 weeks. Hospitalisation is needed for warning signs, bleeding, very low platelets, or dehydration.

Eliminate standing water around the home (flowerpot saucers, coolers, buckets, discarded tyres — dengue mosquitoes breed in tiny water sources). Use mosquito repellent (DEET, picaridin), wear long sleeves at dawn and dusk, use mosquito nets over beds, screens on windows. In malaria-endemic areas, prophylactic medication may be advised before travel. Community-level water management matters as much as individual measures.

Yes, particularly in the north-east states (Odisha, Chhattisgarh, Jharkhand, Meghalaya), tribal areas, and parts of coastal India. Both P. vivax and the more severe P. falciparum occur. Fever with chills that comes in cycles suggests malaria — blood tests confirm the species. Treatment is well-established but drug resistance in P. falciparum makes early diagnosis important. India aims for malaria elimination by 2030.

Chikungunya, also spread by dengue mosquitoes, causes fever and severe joint pain — often more prolonged than dengue (weeks to months of joint pain). It rarely causes the bleeding complications of dengue, but the long-lasting arthritis can be debilitating. Diagnosis is by blood test. Treatment is symptomatic — hydration, rest, paracetamol, physiotherapy for prolonged joint symptoms. No specific antiviral exists.

Typhoid, hepatitis A and E, cholera, dysentery (bacterial and amoebic), gastroenteritis from various viruses and bacteria, and — in specific outbreaks — leptospirosis after monsoon flooding. All spread through water or food contaminated by human faeces. Rates are highest in monsoon season, in areas with poor sanitation, and after floods.

Reputable brands from sealed bottles are generally safe. Local unbranded bottled water is variable — some is just tap water in a bottle. Look for BIS marking. Filtered water from a good home filter (UV + RO for most areas) is often more reliable long-term. Boiled water (rolling boil for 1-3 minutes) is a fallback anywhere. Ice, uncooked food washed in tap water, and street juices are common overlooked risks.

Typhoid causes a gradually rising fever over days, headache, abdominal discomfort, sometimes constipation or diarrhoea, and — classically — a rose-coloured rash on the trunk. Untreated, it can last weeks and cause serious complications (intestinal perforation, bleeding). Diagnosis is by blood culture. Treatment is with specific antibiotics; resistance to older antibiotics is common in India, so choice matters. Vaccine exists and is worth considering for travel or repeated exposure.

Cholera causes profuse watery diarrhoea and rapid dehydration — deadly if fluids aren't replaced quickly. Vibrio cholerae bacteria spread through contaminated water. India still sees cholera outbreaks, especially in poor sanitation areas and after natural disasters. Vaccination (oral cholera vaccine) is used in outbreak settings and for travellers to endemic areas. Prompt fluid replacement with ORS saves lives.

Boiling (rolling boil for 1-3 minutes) is the surest short-term method. Long-term: a good filter combining sediment filtration, activated carbon, RO (for hard/high-TDS water), and UV disinfection. Change filters as scheduled — an old filter is worse than no filter. Store treated water in clean, covered containers. Don't let children drink from open tanks or wells.

A positive RDT confirms malaria and shifts focus immediately to two things: (a) determining severity, a doctor evaluates whether it is uncomplicated malaria (treatable at home with oral antimalarials) or severe malaria (needs hospitalisation and IV artesunate). Severe malaria indicators include altered consciousness, seizures, jaundice, dark urine, breathing difficulty, or extreme weakness. (b) identifying species, this determines the drug regimen. For P. falciparum in India, artemisinin combination therapy (ACT) is first-line; for P. vivax, chloroquine plus primaquine (primaquine treats the dormant liver stage to prevent relapse). The doctor will also order a follow-up blood smear to quantify parasite load and check response to treatment at day 3. Do not self-treat with over-the-counter antimalarials on a positive RDT, the wrong drug or dose can drive resistance and worsen outcomes.

MDR-TB is TB resistant to at least isoniazid and rifampicin, the two most powerful first-line drugs. This resistance usually develops when patients receive inadequate treatment (wrong drugs, wrong doses, insufficient duration, or interruption), surviving bacteria multiply and become resistant. XDR-TB (extensively drug-resistant TB) is even more resistant, adding resistance to fluoroquinolones and injectable second-line drugs. India has among the largest number of MDR-TB cases globally. Treatment takes 9-24 months (vs 6 months for drug-sensitive TB), involves 4-7 medications simultaneously, causes more side effects, costs significantly more, and has lower cure rates (roughly 60-75% vs 85-95% for drug-sensitive TB). India's NTEP provides free MDR-TB diagnosis (GeneXpert MTB/RIF plus line probe assays) and treatment through dedicated DR-TB centres. Key patient rule: never stop TB treatment early even when feeling better, never skip doses, never take TB medications from unknown sources, creating MDR-TB harms both the patient and the community for decades.

BCG (Bacillus Calmette-Guérin) vaccine has real but limited effectiveness. It reliably prevents severe childhood forms of TB. TB meningitis and disseminated (miliary) TB, with efficacy of 60-80%. It is far less effective at preventing adult pulmonary TB, with published efficacy ranging from 0% to 80% depending on the population studied, the variability itself is a major research puzzle, possibly related to prior exposure to environmental mycobacteria in different geographies. Despite this variability, India continues universal BCG vaccination at birth because the severe childhood TB prevention justifies it in a high-burden country; deaths from meningitis or miliary TB in unvaccinated Indian infants would be substantial. Improved TB vaccines are in active development globally (M72/AS01E is in phase 3 trials), but until one is approved, BCG remains standard for Indian newborns and provides genuine protection for the childhood forms that matter most in the neonatal period.

Getting infected and getting sick are two different things. Roughly one-third of the global population carries M. tuberculosis in latent form after some exposure, but only 5-10% ever develop active disease. Whether you progress from infection to active disease depends on multiple factors: immune status (HIV infection multiplies risk 20-30 times, diabetes doubles risk, aging weakens immunity), nutritional status (malnutrition dramatically increases risk), co-existing lung damage (smoking, silicosis, previous TB), genetic factors (specific HLA variants affect susceptibility), medications suppressing immunity (steroids, chemotherapy, TNF inhibitors), and the initial infecting dose. In India, the confluence of high HIV in some regions, high diabetes prevalence (over 100 million adults), household crowding, and undernutrition explains why India carries such a disproportionate share of the global TB burden despite decades of control efforts.

NS1 (nonstructural protein 1) is a glycoprotein made by the dengue virus during its replication inside human cells. It is secreted into the bloodstream in large quantities from day 1 of infection, reaching detectable levels typically within 24 hours of fever onset and remaining detectable through roughly day 5-7. This early appearance makes NS1 uniquely useful because it fills the diagnostic gap before your body has produced detectable antibodies (IgM appears around day 5-7, IgG around day 7-14). NS1 is highly specific to flaviviruses (dengue, Zika, yellow fever), so a positive result in an Indian patient with fever during dengue season is almost certainly dengue, since Zika and yellow fever are rare here. Testing methods: ELISA is the lab standard (highest sensitivity); rapid diagnostic test (RDT) kits give point-of-care results in 15-30 minutes with slightly lower sensitivity.

The three anchor diagnoses in most cases: Hyperthermia related to underlying infection or inflammatory process (as evidenced by elevated body temperature above 38°C, warm skin, tachycardia); Deficient Fluid Volume or Risk for Deficient Fluid Volume related to excessive fluid loss from vomiting and insensible loss from fever (evidenced by decreased urine output, dry mucous membranes, tachycardia, hypotension); and Nausea related to gastrointestinal irritation, drug side effects, or central causes (evidenced by patient report and observed retching). Secondary diagnoses to consider based on presentation: Risk for Electrolyte Imbalance, Acute Pain (headache or abdominal), Imbalanced Nutrition Less than Body Requirements if vomiting is protracted, and Risk for Infection Transmission when the underlying cause is a communicable pathogen. Priority ordering follows Maslow, fluid balance first, then temperature, then comfort.

At minimum every 4-6 hours during the acute phase: temperature (route consistent, oral, axillary, or tympanic; note the route), heart rate, blood pressure (including orthostatic if the patient is ambulant), respiratory rate, oxygen saturation, level of consciousness, and pain score. Fluid balance: strict intake and output charting, urine specific gravity or colour observation, weight if possible daily at the same time. Vomiting characterisation: frequency, volume, colour and content (bilious, coffee-ground, undigested food, blood), and relation to food or medication. Assess mucous membranes, skin turgor, and capillary refill each shift for hydration status. In endemic Indian settings, note any petechiae, rash, or bleeding, early signs of severe dengue that shift the care plan significantly.

Establish IV access early, deteriorating patients can lose the option to hydrate orally quickly. Initiate rehydration per protocol (oral rehydration solution if tolerated; IV normal saline or Ringer's lactate if vomiting persists or dehydration is significant), correcting electrolyte deficits based on baseline labs. Administer prescribed antipyretic (paracetamol is first-line; avoid NSAIDs if dengue is on the differential due to bleeding risk) and prescribed antiemetic (ondansetron is common first-line for adults; metoclopramide alternatives). Cooling measures: tepid sponging if temperature is over 39°C, adequate exposure, ambient temperature control. Send off diagnostic samples early. CBC, electrolytes, urea/creatinine, urine routine, and pathogen-specific tests based on epidemiology (dengue NS1, malaria smear, typhoid Widal or blood culture, stool if diarrhoea present). Document baseline for evaluation.

Objective indicators of successful intervention within 24-48 hours: temperature trending down toward 37.5°C or lower without persistent antipyretic dependence; vomiting frequency reduced by at least 50%, patient tolerating small oral fluid volumes; urine output restored to at least 0.5 mL/kg/hour with clearing urine colour; heart rate and blood pressure normalising toward baseline; improving level of consciousness and patient-reported comfort. Red flags requiring escalation to the treating physician: persistent fever above 39°C beyond 48 hours of appropriate antipyretic use, worsening tachycardia despite fluid replacement, oliguria, altered mental status, new bleeding manifestations (particularly relevant in the Indian dengue season), rising creatinine, or persistent inability to tolerate oral intake. The care plan is not a static document, nursing diagnoses should be re-prioritised as the aetiology clarifies from diagnostic workup.

Neither. Malaria is caused by a single-celled parasite called Plasmodium, technically a protozoan, one of the oldest kinds of life on earth. Five species infect humans: P. falciparum (the most dangerous, common in Africa and parts of India's North-East and eastern states), P. vivax (the most widespread in India, causes relapsing infections), P. ovale, P. malariae, and P. knowlesi (rare, mainly South-East Asian forest exposure). Because it is a parasite and not a bacterium or virus, malaria does not respond to antibiotics or antiviral medicines. It needs specific antimalarial drugs, chloroquine, artemisinin-based combinations, or primaquine, depending on the species and drug-resistance pattern in the region.